The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.

Talby, Leila

The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes. [electronic resource] - Leukemia research Jun 2006 - 665-76 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0145-2126

10.1016/j.leukres.2005.10.007 doi


Anthracyclines--administration & dosage
Antigens, CD34--biosynthesis
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Asparaginase--administration & dosage
Blast Crisis--drug therapy
Burkitt Lymphoma--drug therapy
Child
Child, Preschool
Cortisone--administration & dosage
DNA-Binding Proteins--biosynthesis
Drug Resistance, Neoplasm--genetics
Female
Gene Expression Profiling--methods
Gene Expression Regulation, Leukemic--genetics
Humans
Infant
Male
Oligonucleotide Array Sequence Analysis--methods
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Predictive Value of Tests
Proto-Oncogene Proteins c-bcr--biosynthesis
Transcription Factors--biosynthesis
Vincristine--administration & dosage